Dr. Stefan Walzer and Kate Claessens, the experienced consultant on healthcare in the US, are discussing the public acceptance as well as the various reimbursement pathways in the USA. What is the status of digital health care in the USA? How does reimbursement work for the different paths? What changes might we expect with the Biden administration? And what are the next steps to take?
In order to make it even more practical, Anna Forsythe the Managing Partner at Purple Squirrel Economics and expert in global product commercialization and strategic drug development, has joined the discussion in the second half of the discussion. Don't miss these insights as well.
The US market is for sure very interesting for digital healthcare products. This podcast episode will help you to get an idea of your next steps to enter this attractive market.
Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website:
• MArS🎙 [ Ссылка ]
• Apple 🍏 [ Ссылка ]
• Spotify 🎧 [ Ссылка ]
• Amazon music 📶 [ Ссылка ]
MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: [ Ссылка ]
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #usa #diga #digital
